James Jackson is currently the Franchise Director at Adelphi Real World, where they lead the Pain and Cardio/Renal/Metabolic Disease Specific Programme portfolios. With over 17 years of experience in real-world evidence strategies, they have collaborated with the pharmaceutical industry and clinicians to enhance healthcare solutions, resulting in over 50 publications. Previously, James held various positions at Adelphi Real World, including Associate Director and Research Associate. They earned a BA (hons) in Modern English from the University of Bedfordshire between 1996 and 2000.
This person is not in the org chart
This person is not in any teams
This person is not in any offices